Catalyst Pharmaceuticals Inc (CPRX)

Jul 20, 2025

What drives Catalyst Pharmaceuticals Inc. stock priceHigh-octane financial growth - Autocar Professional

Jul 20, 2025

Jul 19, 2025

What analysts say about Catalyst Pharmaceuticals Inc. stockOverwhelming financial success - jammulinksnews.com

Jul 19, 2025

Jul 19, 2025

Is Catalyst Pharmaceuticals Inc. a good long term investmentLightning-fast growth - jammulinksnews.com

Jul 19, 2025

Jul 18, 2025

Catalyst Pharmaceuticals Inc. Stock Analysis and ForecastExceptional profit margins - jammulinksnews.com

Jul 18, 2025

Jul 18, 2025

Why Catalyst Pharmaceuticals Inc. stock is on top investor watchlistsSafe and Smart Investment Picks - Newser

Jul 18, 2025

Jul 17, 2025

Published on: 2025-07-17 22:44:23 - Newser

Jul 17, 2025

Jul 17, 2025

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Yahoo

Jul 17, 2025

Jul 17, 2025

Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics - The Globe and Mail

Jul 17, 2025

Jul 16, 2025

Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock? - Yahoo.co

Jul 16, 2025

Jul 16, 2025

Teacher Retirement System of Texas Sells 2,766 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 16, 2025

Jul 16, 2025

What makes Catalyst Pharmaceuticals Inc. stock price move sharplyFree Stock Tips Group - beatles.ru

Jul 16, 2025

Jul 15, 2025

Why Catalyst Pharmaceuticals Inc. stock attracts strong analyst attentionPro Trader Stock Focus - Newser

Jul 15, 2025

Jul 15, 2025

How Catalyst Pharmaceuticals Inc. stock performs during market volatilityRisk Aware High Growth Picks - Newser

Jul 15, 2025

Jul 12, 2025

Principal Financial Group Inc. Purchases 17,018 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 12, 2025

Jul 10, 2025

Amalgamated Bank Decreases Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 10, 2025

Jul 10, 2025

Cambridge Investment Research Advisors Inc. Takes Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 10, 2025

Jul 09, 2025

GAMMA Investing LLC Acquires 579 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 09, 2025

Jul 08, 2025

Institutional investors in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) lost 3.5% last week but have reaped the benefits of longer-term growth - simplywall.st

Jul 08, 2025

Jul 08, 2025

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by New York State Teachers Retirement System - Defense World

Jul 08, 2025

Jul 07, 2025

Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term - Yahoo Finance

Jul 07, 2025

Jul 07, 2025

Allspring Global Investments Holdings LLC Sells 244,148 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Jul 07, 2025

Jul 04, 2025

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term - Yahoo Finance

Jul 04, 2025

Jul 01, 2025

Catalyst Pharmaceuticals is Now Oversold (CPRX) - Nasdaq

Jul 01, 2025

Jun 26, 2025

Top 3 Health Care Stocks You'll Regret Missing This Quarter - inkl

Jun 26, 2025

Jun 19, 2025

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock - Nasdaq

Jun 19, 2025

Jun 18, 2025

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Reports Strong Q1 2025 Earnings Growth - Yahoo Finance

Jun 18, 2025

Jun 18, 2025

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock - Yahoo Finance

Jun 18, 2025

Jun 16, 2025

Stanley Laman Group Ltd. Acquires New Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat

Jun 16, 2025

Jun 15, 2025

GAMMA Investing LLC Has $1.64 Million Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat

Jun 15, 2025

Jun 15, 2025

Catalyst Pharmaceuticals (NASDAQ:CPRX) Trading Down 5.2% Following Insider Selling - MarketBeat

Jun 15, 2025

Jun 14, 2025

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Insider Sells $42,272.00 in Stock - MarketBeat

Jun 14, 2025

Jun 13, 2025

Trading (CPRX) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 13, 2025

Jun 13, 2025

Preethi Sundaram Implements A Sell Strategy: Offloads $103K In Catalyst Pharmaceuticals Stock - Nasdaq

Jun 13, 2025

Jun 12, 2025

Insider Sell: Preethi Sundaram Sells Shares of Catalyst Pharmaceuticals Inc (CPRX) - GuruFocus

Jun 12, 2025

Jun 12, 2025

Preethi Sundaram Sells 2,324 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock - MarketBeat

Jun 12, 2025

Jun 12, 2025

117,374 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Bought by Bridge City Capital LLC - MarketBeat

Jun 12, 2025

Jun 11, 2025

Director Of Catalyst Pharmaceuticals Sold $5.22M In Stock - Nasdaq

Jun 11, 2025

Jun 11, 2025

Strong Inflows Make Catalyst Stock an Outlier - FXEmpire

Jun 11, 2025

Jun 10, 2025

Insider Sell: Patrick Mcenany Sells 200,000 Shares of Catalyst P - GuruFocus

Jun 10, 2025

Jun 10, 2025

Catalyst Pharmaceuticals, Inc. (CPRX) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Jun 10, 2025

Jun 09, 2025

Catalyst Pharmaceuticals stock soars to all-time high of $26.49 By Investing.com - Investing.com South Africa

Jun 09, 2025

Jun 09, 2025

Catalyst Pharmaceuticals stock soars to all-time high of $26.49 - Investing.com Australia

Jun 09, 2025

Jun 06, 2025

Catalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Jun 06, 2025